In the news
When off-label may mean off-target: How would doctors and insurers navigate demand for a new, narrow Alzheimer’s drug?
October 13, 2020STAT News
Related news
In the news
March 13, 2024
Prime Therapeutics and Capital Rx Create Technology Alliance
Formulary Watch